A Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONO-6950 in Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 13 Jun 2012
At a glance
- Drugs Gemilukast (Primary)
- Indications Asthma
- Focus Adverse reactions
- 17 Jan 2012 Actual end date ( Oct 2011) added as reported by ClinicalTrials.gov.
- 17 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Nov 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.